ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Discussion on the rationality of FIGO 2018 stage IIIC for cervical cancer with oncological outcomes: a cohort study

Li, Zhiqiang; Duan, Hui; Guo, Jianxin; Yang, Ying; Wang, Wuliang; Hao, Min; Li, Weili; Li, Pengfei; Bin, Xiaonong; Lang, Jinghe; Liu, Ping*; Chen, Chunlin*广州医学院; 南方医科大学; 中国医学科学院; 中国医学科学院北京协和医院
Annals of Translational Medicine2022-1DOI: 10.21037/atm-21-6374
4被引9阅读
引用收藏
分享

摘要

Background: This study explored the rationality of the 2018 International Federation of Gynecology and Obstetrics (FIGO) stage IIIC for cervical cancer to determine outcomes. @@@ Methods: We conducted a retrospective study of cervical cancer patients who had received radical surgery or Radiotherapy. Multivariate analysis was used to compare 5-year overall survival (OS) and disease-free survival (DFS) for FIGO 2018 stages IIIA, IIIB, and IIIC cervical cancer patients. Based on tumor-node-metastasis (TNM) staging, IIIC cases were divided into 5 subgroups: T1a, T1b, T2a, T2b, and T3. The 5-year OS and DFS of the different IIIC subgroups were further compared using multivariate analysis. @@@ Results: (I) The 5-year OS for FIGO 2018 IIIA (n=251), IIIB (n=1,824), and IIIC (n=3,137) were 73.7%, 69.0%, and 74.3%, respectively (P<0.001), and DFS rates were 64.3%, 60.6%, and 68.0%, respectively (P<0.001). Multivariate analysis indicated that IIIA was associated with 5-year OS [hazard ratio (HR) =0.998, 95% confidence interval (CI): 0.739-1.349, P=0.990], but there was no significant correlation with DFS (HR =1.081, 95% CI: 0.843-1.387, P=0.539). Compared with IIIC, IIIB had a lower 5-year OS (HR =1.291, 95% CI: 1.135-1.468, P<0.001) and DFS (HR =1.354, 95% CI: 1.215-1.508, P<0.001). (II) The 5-year OS of the T1a group (n=4), T1b group (n=861), T2a group (n=587), T2b (n=641) group, and T3 group (n=1,044) were 100.0%, 81.9%, 76.1%, 74.0%, and 65.0%, respectively (P<0.001), and the 5-year DFS were 100.0%, 74.5%, 65.9%, 72.6%, and 61.3%, respectively (P<0.001). Multivariate analysis indicated that compared with the T1b group, T2a (HR =1.405, 95% CI: 1.076-1.834, P=0.012), T2b (HR =1.592, 95% CI: 1.203-2.108, P=0.001), and T3 (HR =2.495, 95% CI: 1.971-3.157, P<0.001) were associated with a lower 5-year OS. T2a (HR =1.372, 95% CI: 1.108-1.699, P=0.004), T2b (HR =1.337, 95% CI: 1.061-1.684, P=0.014), and T3 (HR =2.015, 95% CI: 1.659-2.446, P<0.001) were associated with lower 5-year DFS. @@@ Conclusions: The outcome for FIGO 2018 stage IIIC cervical cancer is not worse than that for stage IIIB or IIIA. The outcome for stage IIIC is related to local tumor factors. As the local tumor progresses, the oncological outcome worsens.

学科与关键词

关键词
Cervical cancerInternational Federation of Gynecology and Obstetrics staging (FIGO staging)IIIConcological outcomerationality
相关
加载中…
  • Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors
    Ye, Yanna; Li, Zhiqiang; Kang, Shan; Yang, Yongxiu; Ling, Bin; Wang, Li; Yao, Jilong; Li, Pengfei; Wang, Xueqin; Gong, Shipeng; Fan, Huijian; Kong, Yanxiang; Cao, Yuye; Lang, Jinghe; Liu, Ping*; Chen, Chunlin*BMC CANCER, 2023, 23(1): 421.
  • Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14-year multicenter study
    Ye, Yanna; Zhang, Guozhao; Li, Zhiqiang; Chen, Biliang; Zhao, Hongwei; Yang, Ying; Wang, Li; Yao, Jilong; Chen, Xiaolin; Huang, Yahong; Lang, Jinghe; Liu, Ping*; Chen, Chunlin*Cancer Medicine, 2023, 12(19): 19617-19632.
  • Abdominal Radical Hysterectomy as an Alternative Treatment Option for Patients with Cervical Cancer without Access to Radiotherapy Facilities
    Ye, Yanna; Li, Zhiqiang; Chen, Biliang; Kang, Shan; Ling, Bin; Wang, Li; Yao, Jilong; Lan, Jinghe; Liu, Ping*; Chen, Chunlin*Clinical and Experimental Obstetrics & Gynecology, 2023, 50(10): 5010219.
查看全部 →

发表信息

论文状态
公开发表
期刊
Annals of Translational Medicine
发表日期
2022-01
卷期
第 10 卷, 第 2 期
页码
122
DOI
10.21037/atm-21-6374
期刊等级
4区
成果收录
SCIE
资助标注
National Science and Technology Support Program of China [014BAI05B03]; National Natural Science Fund of Guangdong [2015A030311024]; Science and Technology Plan of Guangzhou [158100075]

作者

  • L

    Li, Zhiqiang (第一作者)

    southern med univ

  • D

    Duan, Hui

    southern med univ

查看全部 12 位作者收起作者
  • G

    Guo, Jianxin

  • Y

    Yang, Ying

    xinqiao hosp

  • W

    Wang, Wuliang

    2

  • H

    Hao, Min

    2 · shanxi med univ

  • L

    Li, Weili

    southern med univ

  • L

    Li, Pengfei

    southern med univ

  • B

    Bin, Xiaonong

    guangzhou med univ

  • L

    Lang, Jinghe

    chinese acad med sci · peking union med coll · peking union med coll hosp · southern med univ

  • L

    Liu, Ping (通讯)

    southern med univ

  • C

    Chen, Chunlin (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417